AI assistant
Sending…
PFIZER INC — Director's Dealing 2017
Mar 10, 2017
29831_dirs_2017-03-10_5893918a-65e0-4ec9-8c77-21c94033bf3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2017-03-09
Reporting Person: JOHNSON RADY A (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-09 | Common Stock | I | 4405.0000 | $34.0500 | Acquired | 4821.0000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 59463.0000 | Direct |
Footnotes
F1: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31